SAREPTA THERAPEUTICS INC

CUSIP: 803607AD2 Class: Convertible Debt

PALISADE CAPITAL MANAGEMENT, LP's Holding History (CIK: 0001009006)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,746,000 Value ($000) $1,571 Avg Close Range
Q3 2025
Shares 3,305,000 Value ($000) $2,898 Avg Close Range
Q2 2025
Shares 3,305,000 Value ($000) $2,428 Avg Close Range
Q1 2025
Shares 3,305,000 Value ($000) $3,082 Avg Close Range
Q4 2024
Shares 3,305,000 Value ($000) $3,645 Avg Close Range
Q3 2024
Shares 1,805,000 Value ($000) $2,051 Avg Close Range
Q2 2024
Shares 1,805,000 Value ($000) $2,332 Avg Close Range
Q1 2024
Shares 1,805,000 Value ($000) $2,112 Avg Close Range
Q4 2023
Shares 2,085,000 Value ($000) $2,110 Avg Close Range
Q3 2023
Shares 2,085,000 Value ($000) $2,336 Avg Close Range